News

Dow posts narrow loss after Fed signals it's in no hurry to cut rates: Live updates
The 30-stock Dow lost 44.14 points, or 0.10%, and ended at 42,171.66. The S&P 500 slipped 0.03% to close at 5,980.87, and the ...
Fierce Biotech20h
Scholar Rock's SMA drug helps weight loss patients on Zepbound retain muscle in phase 2 trial
Scholar Rock’s investigational spinal muscular atrophy drug helped patients taking Eli Lilly’s obesity blockbuster Zepbound ...
Eli Lilly is making it cheaper and easier to buy high doses of blockbuster weight-loss drug Zepbound
Patients with obesity can now get Zepbound’s strongest doses for a flat rate through Lilly’s self-pay pharmacy. Eli Lilly ...
PharmExec2d
Lilly Launches Full Zepbound Dose Access for Obesity Through LillyDirect Self-Pay Program
Starting July 7, 2025, the two highest doses of Zepbound will be available for a flat price of $499 per month, with shipments ...
MarketWatch3d
Eli Lilly’s Zepbound pricing shuffle leaves some patients fearing higher costs
Eli Lilly’s Zepbound pricing shuffle leaves some patients fearing higher costs Savings-card price increase jars patients who lack coverage for popular obesity drug Published: Aug. 28, 2024 at 3: ...